BIOSPAIN 2023: Biotechnology emerges as a response to the main challenges Europe is facing 12/09/2023 The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26... AseBio
#BIOSPAIN2023Interview | "The 'biotech' sector is one of the sectors with the greatest fin... 12/09/2023 BioSpain Financing We spoke with Cristina Cortés, manager at Ayming, Bronze Sponsor of BIOSPAIN 2023, about the role of private financing... AseBio - Ayming
#BIOSPAIN2023Interview | "In Spain, there are still few researchers who venture to turn th... 12/09/2023 BioSpain We spoke with Raúl Martín-Ruiz, partner at Ysios Capital, Gold Sponsor of BIOSPAIN 2023, about how to transform... AseBio - Ysios Capital Partners
#BIOSPAIN2023 Interview | "The Administration of LAM561 Shows Promising Results in the Tr... 08/09/2023 Innovative drugs BioSpain We spoke with Cati Ana Rosselló, Head of CMC at Laminar Pharma, a Bronze Sponsor of BIOSPAIN 2023, about the results of... AseBio - Laminar Pharma
#BIOSPAIN2023Interview | "It is good news that the CNMV has laid the foundations to measu... 07/09/2023 Healthcare BioSpain We spoke with Clara Campàs, director and co-founder of Asabys, Gold Sponsor of BIOSPAIN 2023, to learn all the details... AseBio - Asabys Partners
ShapingBio will analyze the challenges and opportunities of the bioeconomy in Europe at BI... 07/09/2023 BioSpain The European project ShapingBio, created with the aim of better understanding and enhancing knowledge of the innovation... AseBio
ShapingBio will analyze the challenges and opportunities of the bioeconomy in Europe at BI... 07/09/2023 The European project ShapingBio, created with the aim of better understanding and gaining knowledge of the innovation... AseBio
#BIOSPAIN2023Interview | "We are facing a paradigm shift in Drug Discovery" 06/09/2023 BioSpain Víctor Guallar, Chief Scientific Officer of Nostrum Biodiscovery, Silver Sponsor of BIOSPAIN 2023, analyzes the current... AseBio - Nostrum Biodiscovery
ORYZON to give updates on corporate progress in September 05/09/2023 BioSpain Communication The international conferences that will be attended include the H.C. Wainwright Global Investment Conference in New York... Partners - Oryzon Genomics
#BIOSPAIN2023Interview | "Patients with a rare disease face a large number of unmet needs" 04/09/2023 BioSpain We talk about the role of patients in developing solutions for rare diseases with Annabel de Maria, Chief Patient... AseBio
